• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类产志贺毒素大肠杆菌感染的综合诊断方法。

Integrated Approach for the Diagnosis of Shiga Toxin-Producing Escherichia coli Infections in Humans.

机构信息

Istituto Superiore di Sanità, Rome, Italy.

出版信息

Methods Mol Biol. 2021;2291:1-17. doi: 10.1007/978-1-0716-1339-9_1.

DOI:10.1007/978-1-0716-1339-9_1
PMID:33704747
Abstract

Shiga toxin-producing Escherichia coli (STEC) are human pathogens causing severe diseases, such as hemorrhagic colitis and the hemolytic uremic syndrome. The prompt diagnosis of STEC infection is of primary importance to drive the most appropriate patient's management procedures. The methods to diagnose STEC infections include both direct isolation of the STEC from stool samples and the identification of indirect evidences based on molecular, phenotypic, and serological applications. Here, the procedures in use at the Italian Reference Laboratory for E. coli infections are described.

摘要

产志贺毒素大肠杆菌(STEC)是人类病原体,可引起严重疾病,如出血性结肠炎和溶血尿毒综合征。及时诊断 STEC 感染对于推动最适当的患者管理程序至关重要。诊断 STEC 感染的方法包括直接从粪便样本中分离 STEC 和基于分子、表型和血清学应用的间接证据的鉴定。本文描述了意大利大肠杆菌感染参考实验室使用的程序。

相似文献

1
Integrated Approach for the Diagnosis of Shiga Toxin-Producing Escherichia coli Infections in Humans.人类产志贺毒素大肠杆菌感染的综合诊断方法。
Methods Mol Biol. 2021;2291:1-17. doi: 10.1007/978-1-0716-1339-9_1.
2
A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.一种用于改善从人类粪便标本中诊断和分离产志贺毒素大肠杆菌的多重方案。
Diagn Microbiol Infect Dis. 2008 Sep;62(1):7-10. doi: 10.1016/j.diagmicrobio.2008.05.001. Epub 2008 Jun 11.
3
Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.波兰溶血尿毒综合征患儿对产志贺毒素大肠杆菌(STEC)脂多糖和重组蛋白的抗体反应。
Lett Appl Microbiol. 2020 Jun;70(6):440-446. doi: 10.1111/lam.13295. Epub 2020 Apr 28.
4
Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay.与培养法、酶免疫测定法和Vero细胞细胞毒性测定法相比,通过实时PCR直接从粪便样本中快速灵敏地检测产志贺毒素大肠杆菌。
Clin Lab. 2011;57(11-12):993-8.
5
Shiga Toxin Producing Escherichia coli-Hemolytic Uremic Syndrome Mimicking Acute Severe Ulcerative Colitis in a Child With Bloody Diarrhea.产志贺毒素大肠杆菌-溶血尿毒综合征在一名患有血性腹泻的儿童中酷似急性重症溃疡性结肠炎。
Inflamm Bowel Dis. 2019 Jul 17;25(8):e92-e93. doi: 10.1093/ibd/izz058.
6
Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.出血性尿毒症综合征患儿家庭成员中产志贺毒素大肠埃希菌。
Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):427-432. doi: 10.1007/s10096-019-03738-1. Epub 2019 Nov 28.
7
Molecular Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated in Poland.波兰分离的产志贺毒素大肠杆菌菌株的分子特征
Pol J Microbiol. 2016 Aug 26;65(3):261-269. doi: 10.5604/17331331.1215601.
8
Rapid culture-free identification and molecular typing of Shiga toxin-producing Escherichia coli by PCR-RFLP.通过聚合酶链反应-限制性片段长度多态性技术对产志贺毒素大肠杆菌进行快速免培养鉴定及分子分型
Microbiol Immunol. 2008 Jun;52(6):310-3. doi: 10.1111/j.1348-0421.2008.00038.x.
9
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.溶血性尿毒症综合征:与炎症性肠病发作的鉴别诊断。
Acta Biomed. 2018 Dec 17;89(9-S):153-157. doi: 10.23750/abm.v89i9-S.7911.
10
Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories.临床实验室对产志贺毒素大肠杆菌感染的诊断建议。
MMWR Recomm Rep. 2009 Oct 16;58(RR-12):1-14.

本文引用的文献

1
Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.志贺毒素引起的溶血尿毒综合征和抗生素的作用:全球概述。
J Infect. 2019 Aug;79(2):75-94. doi: 10.1016/j.jinf.2019.05.018. Epub 2019 May 28.
2
Haemolytic uremic syndrome surveillance in children less than 15 years in Belgium, 2009-2015.2009 - 2015年比利时15岁以下儿童溶血性尿毒症综合征监测
Arch Public Health. 2018 Aug 6;76:41. doi: 10.1186/s13690-018-0289-x. eCollection 2018.
3
Whole-Genome Characterization and Strain Comparison of VT2f-Producing Escherichia coli Causing Hemolytic Uremic Syndrome.
产志贺毒素2f致溶血性尿毒综合征大肠杆菌的全基因组特征分析及菌株比较
Emerg Infect Dis. 2016 Dec;22(12):2078-2086. doi: 10.3201/eid2212.160017. Epub 2016 Dec 15.
4
Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.产志贺毒素大肠杆菌感染、抗生素与溶血尿毒综合征发生风险:一项荟萃分析
Clin Infect Dis. 2016 May 15;62(10):1251-1258. doi: 10.1093/cid/ciw099. Epub 2016 Feb 24.
5
Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal.产志贺毒素大肠杆菌(VTEC)感染的抗生素治疗:一项系统评价及建议
J Antimicrob Chemother. 2015 Sep;70(9):2440-6. doi: 10.1093/jac/dkv162. Epub 2015 Jun 20.
6
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.基于序列的肠出血性大肠杆菌 O157:H7 志贺毒素分型方案的多中心评估和 Stx 命名标准化。
J Clin Microbiol. 2012 Sep;50(9):2951-63. doi: 10.1128/JCM.00860-12. Epub 2012 Jul 3.
7
Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.志贺毒素相关性溶血尿毒综合征:发病机制和治疗学的进展。
Curr Opin Nephrol Hypertens. 2012 Jul;21(4):433-40. doi: 10.1097/MNH.0b013e328354a62e.
8
Management of hemolytic uremic syndrome.溶血尿毒综合征的管理
Presse Med. 2012 Mar;41(3 Pt 2):e115-35. doi: 10.1016/j.lpm.2011.11.013. Epub 2012 Jan 27.
9
Diagnostic real-time PCR assays for the detection of emetic Bacillus cereus strains in foods and recent food-borne outbreaks.用于检测食品中致吐性蜡样芽孢杆菌菌株及近期食源性疾病暴发的诊断实时聚合酶链反应检测方法。
Appl Environ Microbiol. 2007 Mar;73(6):1892-8. doi: 10.1128/AEM.02219-06. Epub 2007 Jan 26.
10
Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction.通过实时聚合酶链反应检测大肠杆菌O103血清型
J Appl Microbiol. 2005;98(5):1162-8. doi: 10.1111/j.1365-2672.2005.02545.x.